Abeona Therapeutics Inc ABEO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:46 AM EDT
1.64quote price arrow down-0.03 (-2.08%)
Volume
960,517
52 week range
0.99 - 3.79

...

Loading . . .
  • Open1.77
  • Day High1.79
  • Day Low1.61
  • Prev Close1.68
  • 52 Week High3.79
  • 52 Week High Date02/09/21
  • 52 Week Low0.99
  • 52 Week Low Date11/03/20

Key Stats

  • Market Cap162.92M
  • Shares Out99.04M
  • 10 Day Average Volume1.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • YTD % Change3.26

KEY STATS

  • Open1.77
  • Day High1.79
  • Day Low1.61
  • Prev Close1.68
  • 52 Week High3.79
  • 52 Week High Date02/09/21
  • 52 Week Low0.99
  • 52 Week Low Date11/03/20
  • Market Cap162.92M
  • Shares Out99.04M
  • 10 Day Average Volume1.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • YTD % Change3.26

RATIOS/PROFITABILITY

  • EPS (TTM)-0.91
  • P/E (TTM)-1.81
  • Fwd P/E (NTM)-2.46
  • EBITDA (MRQ)-43.918M
  • ROE (MRQ)-59.96%
  • Revenue (MRQ)10.00M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-842.34%
  • Debt To Equity (MRQ)1.71%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Abeona Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB). It is also developing ABO-101 (AAV-NAGLU) for Sanfilippo syndrome type B (MPS IIIB)...
Michael Amoroso
President
Edward Carr
Chief Financial Officer
Address
1330 Avenue of the Americas Fl 33
New York, NY
10019-5442
United States

Top Peers

SYMBOLLASTCHG%CHG
JAGX
Jaguar Health Inc
1.63+0.19+13.19%
CLSD
Clearside Biomedical Inc
2.86-0.08-2.72%
GLYC
GlycoMimetics Inc
2.51-0.02-0.99%
CNCE
Concert Pharmaceuticals Inc
4.36-0.09-2.02%
ORGS
Orgenesis Inc
5.13+0.09+1.79%